MedTrace Logo

Promotion of Vaginal Health With CH2 Vaginal Gel After Pelvic Radiotherapy

NCT06997887 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-06-27

No results posted yet for this study

Summary

This is a prospective clinical trial planning to enroll female patients who have completed pelvic radiotherapy. Participants will undergo a 12-week intervention with either CH2 vaginal gel or vaginal rehabilitation exercises. The primary endpoint is the change in the Female Sexual Function Index scores.

Conditions

  • Gynecologic Malignancy

Interventions

OTHER

CH2 vaginal gel

12-week intervention with CH2 vaginal gel

OTHER

vaginal rehabilitation exercises

12-week intervention with vaginal rehabilitation exercises

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Jenny Ling-Yu Chen Professor, Attending Physician, MD PhD · National Taiwan University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-09
Primary Completion
2028-05-09
Completion
2030-05-09

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06997887 on ClinicalTrials.gov